Brief: OSE Immunotherapeutics Provides Positive Long Term Responses With CoVepiT Anti-Covid Vaccine

Ose Immunotherapeutics SA

16/03/2022 17:41

March 16 (Reuters) - OSE Immunotherapeutics SA  OSE.PA :
    * OSE IMMUNOTHERAPEUTICS PROVIDES POSITIVE LONG TERM MEMORY
RESPONSES WITH COVEPIT, ITS T LYMPHOCYTE MULTI-TARGET ANTI-COVID
VACCINE
    * VACCINE REMAINS INDEPENDENT OF MUTATIONS IDENTIFIED IN
CURRENT
AND EMERGING VARIANTS
    * POSITIVE LONG TERM IMMUNOLOGICAL RESULTS AT 6 MONTHS IN
HEALTHY
VOLUNTEERS WITH STRONG T CELL MEMORY RESPONSES AGAINST VIRUS
PROTEINS
    * THIS LONG TERM POSITIVE IMMUNE RESPONSE IS OF STRONG
INTEREST AS
MORE MULTISPECIFIC MEMORY T CELLS ARE EXPECTED TO BE EFFICIENT
FOR IMMUNOCOMPROMISED PATIENTS IN CASE OF ANY NEW EMERGING
CORONAVIRUS OR VARIANTS OF CONCERN

Source text for Eikon:  urn:newsml:reuters.com:*:nBwznd51a
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))